Page last updated: 2024-11-05

tetraisopropylpyrophosphamide and Glioma

tetraisopropylpyrophosphamide has been researched along with Glioma in 1 studies

Tetraisopropylpyrophosphamide: N,N',N'',N'''-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Razon, N1
Soreq, H1
Roth, E1
Bartal, A1
Silman, I1

Other Studies

1 other study available for tetraisopropylpyrophosphamide and Glioma

ArticleYear
Characterization of activities and forms of cholinesterases in human primary brain tumors.
    Experimental neurology, 1984, Volume: 84, Issue:3

    Topics: Acetylcholinesterase; Adolescent; Adult; Aged; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-di

1984